These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15922930)

  • 1. Roger Perlmutter on shaping Amgen's R&D strategy. Interview by Christopher Watson.
    Perlmutter RM
    Drug Discov Today; 2005 Jun; 10(11):745-8. PubMed ID: 15922930
    [No Abstract]   [Full Text] [Related]  

  • 2. Amgen's big-ticket play for Immunex.
    Fletcher L
    Nat Biotechnol; 2002 Feb; 20(2):105-6. PubMed ID: 11821840
    [No Abstract]   [Full Text] [Related]  

  • 3. Amgen's Japan deal.
    Ratner M
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392006
    [No Abstract]   [Full Text] [Related]  

  • 4. Amgen's NESP victory cuts out Johnson & Johnson.
    Fürst I
    Nat Biotechnol; 1999 Feb; 17(2):124. PubMed ID: 10052335
    [No Abstract]   [Full Text] [Related]  

  • 5. Can 'double blockbuster' strengthen Amgen's backbone?
    Sheridan C
    Nat Biotechnol; 2008 Apr; 26(4):361-3. PubMed ID: 18391999
    [No Abstract]   [Full Text] [Related]  

  • 6. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth in R&D investment holding up.
    Chipman A
    Nature; 2009 Nov; 462(7271):264. PubMed ID: 19924181
    [No Abstract]   [Full Text] [Related]  

  • 8. Yike Guo and Jonathan Sheldon of InforSense discuss the impact of workflow technology on drug discovery. Interview by Christopher Watson.
    Guo Y; Sheldon J
    Drug Discov Today; 2005 Sep; 10(18):1211-2. PubMed ID: 16213411
    [No Abstract]   [Full Text] [Related]  

  • 9. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 10. Robert Stoll. Interview by Charlotte Harrison.
    Stoll R
    Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
    [No Abstract]   [Full Text] [Related]  

  • 11. Alice Huxley and Nick Miles of Speedel on the company's pipeline and future plans. Interview by Christopher Watson and Stephen Carney.
    Huxley A; Miles N
    Drug Discov Today; 2005 Jul; 10(13):881-3. PubMed ID: 15993805
    [No Abstract]   [Full Text] [Related]  

  • 12. Amgen's bispecific antibody puffs across finish line.
    Sheridan C
    Nat Biotechnol; 2015 Mar; 33(3):219-21. PubMed ID: 25748895
    [No Abstract]   [Full Text] [Related]  

  • 13. Bring the magic back to the bullets.
    Nat Biotechnol; 2006 Dec; 24(12):1489. PubMed ID: 17160046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The science-business tango. Interview by Mari Paul.
    Hirth P
    Nat Biotechnol; 2006 Aug; 24(8):1035-6. PubMed ID: 16900153
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech R&D goes further afield.
    Lawrence S
    Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201
    [No Abstract]   [Full Text] [Related]  

  • 16. Sarbanes-Oxley rules to be relaxed?
    Lawrence S
    Nat Biotechnol; 2006 Jul; 24(7):731-2. PubMed ID: 16841042
    [No Abstract]   [Full Text] [Related]  

  • 17. Singapore R&D and globetrotting.
    Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
    Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting pharmacogenetics into practice.
    Hopkins MM; Ibarreta D; Gaisser S; Enzing CM; Ryan J; Martin PA; Lewis G; Detmar S; van den Akker-van Marle ME; Hedgecoe AM; Nightingale P; Dreiling M; Hartig KJ; Vullings W; Forde T
    Nat Biotechnol; 2006 Apr; 24(4):403-10. PubMed ID: 16601719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intellectual property. Research centers promise a break on medical patents in developing countries.
    Kean S
    Science; 2009 Nov; 326(5956):1051. PubMed ID: 19965400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.